Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia (Q30436996)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia |
scientific article |
Statements
1 reference
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia (English)
1 reference
Georg Aue
1 reference
Margaret A Lindorfer
1 reference
Paul V Beum
1 reference
Andrew W Pawluczkowycz
1 reference
Berengere Vire
1 reference
Thomas Hughes
1 reference
Ronald P Taylor
1 reference
Adrian Wiestner
1 reference
13 August 2009
1 reference
1 reference
329-332
1 reference
Identifiers
1 reference
1 reference
1 reference